Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 5 months ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia
Radcliffe & CardioNerds @AHA22: PROGRESSIVE-AF: Impact of “First-Line” Rhythm Therapy on Afib Progression
Author(s): Jason G Andrade , Kate Wilcox Added: 1 year ago
AHA 22 - Dr Kate Wilcox, CardioNerds Academic Fellow (Medical College of Wisconsin, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Dr Jason Andrade (Vancouver General/Montreal Heart Institute, CA), investigator of the late-breaking PROGRESSIVE-AF trial (NCT05514860). The aim of PROGRESSIVE-AF is to assess if the initial treatment choice,… View more

Electrophysiology & Arrhythmia
Author(s): Miriam García Bermúdez , Antonia Ortega Diaz , Ana Bonet Basiero , et al Added: 3 years ago
Topic: 4. Arrhythmias Introduction and Objectives The more time the heart rhythm is evaluated, the more rhythm disturbances are diagnosed in patients with syncope, palpitations or cryptogenic stroke. Increasing from 24-48h to 30 days with external holter allows further registering cardiac rhythm without invasive and expensive techniques such as ILR (implantable loop recorder). Moreover, it… View more

Electrophysiology & Arrhythmia
Author(s): Gianluigi Savarese Added: 3 years ago
Cardiovascular (CV) disease is the leading cause of death worldwide.1 Age, sex and genetic factors have a major impact on CV risk. The importance of behavioural factors, such as tobacco and alcohol use, physical inactivity, unhealthy diet and obesity, is often neglected, although the implementation of lifestyle changes may be a cost-effective strategy for the prevention of CV diseases, also from… View more

Prevention & Chronic Conditions
TCT 23: WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR
Author(s): Samir R Kapadia Added: 5 months ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more

Electrophysiology & Arrhythmia

Intervention
Author(s): Antonio J Vallejo-Vaz Added: 3 years ago
Elevated LDL cholesterol (LDL-C) plays a major role in the development of atherosclerotic cardiovascular disease (ASCVD). Multiple studies and meta-analyses, including randomised controlled trials, prospective cohort studies and Mendelian randomisation studies, have consistently shown an association between LDL-C and ASCVD risk that is proportional to the magnitude and duration of exposure to… View more

Prevention & Chronic Conditions
APSC Consensus Recommendations on Dyslipidaemia
Author(s): Natalie Koh , Brian Ference , Stephen J Nicholls , et al Added: 2 years ago

Standards & Guidelines

Prevention & Chronic Conditions
ECR Nicholls
Author(s): Stephen J Nicholls Added: 3 years ago
Therapeutic targeting of dyslipidaemia has been one of the major successes in cardiovascular medicine over the last three decades. On the basis of unequivocal evidence from animal models through to both population and genetic studies in humans, there is a clear association between increasing levels of LDL cholesterol (LDL-C) and incident cardiovascular risk.1 This has prompted efforts to develop… View more

Prevention & Chronic Conditions
PCSK9 Inhibition: The Big Step Forward in Lipid Control
Author(s): Rishi Rikhi , Michael D Shapiro Added: 9 months ago

Vascular Disease and Surgery

Prevention & Chronic Conditions
Author(s): Kevin Cheng , Ranil de Silva Added: 2 years ago

Prevention & Chronic Conditions